Mirae Asset Global Investments Co., Ltd. Adverum Biotechnologies, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $22.5 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
SELL
$0.81 - $1.34 $313,974 - $519,414
-387,623 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$1.23 - $1.95 $48,443 - $76,800
-39,385 Reduced 9.22%
387,623 $508,000
Q4 2021

Feb 08, 2022
BUY
$1.74 - $2.4 $275,015 - $379,332
158,055 Added 58.77%
427,008 $752,000
Q3 2021

Nov 15, 2021
BUY
$2.08 - $3.6 $105,139 - $181,972
50,548 Added 23.14%
268,953 $584,000
Q2 2021

Aug 11, 2021
BUY
$3.36 - $10.56 $83,781 - $263,313
24,935 Added 12.89%
218,405 $765,000
Q1 2021

May 13, 2021
BUY
$9.26 - $14.36 $814,426 - $1.26 Million
87,951 Added 83.35%
193,470 $1.91 Million
Q4 2020

Feb 10, 2021
BUY
$9.84 - $14.26 $375,789 - $544,589
38,190 Added 56.72%
105,519 $1.14 Million
Q3 2020

Nov 12, 2020
BUY
$10.3 - $21.64 $218,772 - $459,633
21,240 Added 46.08%
67,329 $694,000
Q2 2020

Aug 11, 2020
BUY
$8.53 - $25.64 $208,114 - $625,564
24,398 Added 112.48%
46,089 $962,000
Q1 2020

May 12, 2020
BUY
$7.98 - $16.32 $18,880 - $38,613
2,366 Added 12.24%
21,691 $212,000
Q4 2019

Feb 12, 2020
BUY
$5.12 - $12.22 $11,740 - $28,020
2,293 Added 13.46%
19,325 $222,000
Q3 2019

Nov 12, 2019
BUY
$5.24 - $15.89 $89,247 - $270,638
17,032 New
17,032 $93,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email